NCT07177560View on ClinicalTrials.gov

Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)

CompletedOBSERVATIONAL

Enrollment

151

Participants

Timeline

Start Date

July 30, 2023

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2024

Conditions

Colorectal CancerGastric Cancer (GC)CapecitabineHand Foot Syndrome

Trial Locations (2)

Unknown

Ankara Etlik City Hospital, Ankara

Gazi University, Ankara

All Listed Sponsors

lead

Gazi University

OTHER